Halozyme Therapeutics, Inc. Company Information
Halozyme Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Halozyme Therapeutics, Inc.
- Ticker: HALO
- Exchange: NasdaqGS
- Founded: 1998
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$5.701b
- Shares Outstanding: 127.23m
- Website: https://halozyme.com
Number of Employees
Location
- Halozyme Therapeutics, Inc.
- 12390 El Camino Real
- San Diego
- California
- 92130
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HALO | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jan 2003 |
| RV7 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 2003 |
| 0J2O | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 2003 |
| HALO * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 2003 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/20 11:00 |
| End of Day Share Price | 2024/11/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.